Santana VM - Search Results

1

Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts.

Zamboni WC, Stewart CF, Thompson J, Santana VM, Cheshire PJ, Richmond LB, Luo X, Poquette C, Houghton JA, Houghton PJ. Zamboni WC, et al. Among authors: santana vm. J Natl Cancer Inst. 1998 Apr 1;90(7):505-11. doi: 10.1093/jnci/90.7.505. J Natl Cancer Inst. 1998. PMID: 9539245

2

Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors.

Santana VM, Schell MJ, Williams R, Bowman LC, Thompson EI, Brenner MK, Mirro J Jr. Santana VM, et al. Bone Marrow Transplant. 1992 Nov;10(5):457-62. Bone Marrow Transplant. 1992. PMID: 1464010 Clinical Trial.

3

Infants with metastatic neuroblastoma have improved survival with resection of the primary tumor.

DeCou JM, Bowman LC, Rao BN, Santana VM, Furman WL, Luo X, Lobe TE, Kumar M. DeCou JM, et al. Among authors: santana vm. J Pediatr Surg. 1995 Jul;30(7):937-40; discussion 940-1. doi: 10.1016/0022-3468(95)90316-x. J Pediatr Surg. 1995. PMID: 7472948

4

Complete hematologic remissions induced by 2-chlorodeoxyadenosine in children with newly diagnosed acute myeloid leukemia.

Santana VM, Hurwitz CA, Blakley RL, Crom WR, Luo X, Roberts WM, Ribeiro R, Mahmoud H, Krance RA. Santana VM, et al. Blood. 1994 Aug 15;84(4):1237-42. Blood. 1994. PMID: 7914104 Free article.

5

Phase I study of topotecan for pediatric patients with malignant solid tumors.

Pratt CB, Stewart C, Santana VM, Bowman L, Furman W, Ochs J, Marina N, Kuttesch JF, Heideman R, Sandlund JT, et al. Pratt CB, et al. Among authors: santana vm. J Clin Oncol. 1994 Mar;12(3):539-43. doi: 10.1200/JCO.1994.12.3.539. J Clin Oncol. 1994. PMID: 8120551 Clinical Trial.

6

A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma.

Pappo AS, Etcubanas E, Santana VM, Rao BN, Kun LE, Fontanesi J, Roberson PK, Bowman LC, Crist WM, Shapiro DN. Pappo AS, et al. Among authors: santana vm. Cancer. 1993 Mar 15;71(6):2119-25. doi: 10.1002/1097-0142(19930315)71:6<2119::aid-cncr2820710629>3.0.co;2-y. Cancer. 1993. PMID: 8443761 Clinical Trial.

7

Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study.

Tubergen DG, Stewart CF, Pratt CB, Zamboni WC, Winick N, Santana VM, Dryer ZA, Kurtzberg J, Bell B, Grier H, Vietti TJ. Tubergen DG, et al. Among authors: santana vm. J Pediatr Hematol Oncol. 1996 Nov;18(4):352-61. doi: 10.1097/00043426-199611000-00004. J Pediatr Hematol Oncol. 1996. PMID: 8888741 Clinical Trial.

8

Blindness in children with neuroblastoma.

Belgaumi AF, Kauffman WM, Jenkins JJ, Cordoba J, Bowman LC, Santana VM, Furman WL. Belgaumi AF, et al. Among authors: santana vm. Cancer. 1997 Nov 15;80(10):1997-2004. Cancer. 1997. PMID: 9366304

9

Extending principles learned in model systems to clinical trials design.

Houghton PJ, Stewart CF, Thompson J, Santana VM, Furman WL, Friedman HS. Houghton PJ, et al. Among authors: santana vm. Oncology (Williston Park). 1998 Aug;12(8 Suppl 6):84-93. Oncology (Williston Park). 1998. PMID: 9726098 Free article.

10

Interpatient variability in bioavailability of the intravenous formulation of topotecan given orally to children with recurrent solid tumors.

Zamboni WC, Bowman LC, Tan M, Santana VM, Houghton PJ, Meyer WH, Pratt CB, Heideman RL, Gajjar AJ, Pappo AS, Stewart CF. Zamboni WC, et al. Among authors: santana vm. Cancer Chemother Pharmacol. 1999;43(6):454-60. doi: 10.1007/s002800050923. Cancer Chemother Pharmacol. 1999. PMID: 10321504

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page